Immunologic Research

, Volume 61, Issue 1–2, pp 135–140 | Cite as

A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies

  • O. Shovman
  • N. Agmon-Levin
  • B. Gilburd
  • T. Martins
  • A. Petzold
  • T. Matthias
  • Y. Shoenfeld
DIAGNOSTICS AND ENVIRONMENTAL FACTORS

Abstract

Indirect immunofluorescence (IIF) is the main technique for the detection of antinuclear antibodies (ANA) and antineutrophil cytoplasmic antibodies (ANCA). The fully automated IIF processor HELIOS® is the first IIF processor that is able to automatically prepare slides and perform automatic reading. The objective of the present study was to determine the diagnostic performance of this system for ANA and ANCA IIF interpretation, in comparison with visual IIF. ANA detection by visual IIF or HELIOS® was performed on 425 sera samples including: 218 consecutive samples submitted to a reference laboratory for routine ANA testing, 137 samples from healthy subjects and 70 ANA/ENA positive samples. For ANCA determination, 170 sera samples were collected: 40 samples for routine testing, 90 samples from healthy blood donors and 40 anti-PR3/anti-MPO positive subjects. Good correlation was found for the visual and automated ANA IIF approach regarding positive/negative discrimination of these samples (kappa = 0.633 for ANA positive samples and kappa = 0.657 for ANA negative samples, respectively). Positive/negative IIF ANCA discrimination by HELIOS® and visual IIF revealed a complete agreement of 100 % in sera from healthy patients and PR3/MPO positive samples (kappa = 1.00). There was 95 % agreement between the ANCA IIF performed by automated and visual IIF on the investigation of routine samples. Based on these results, HELIOS® demonstrated a high diagnostic performance for the automated ANA and ANCA IIF interpretation that was similar to a visual reading in all groups of samples.

Keywords

Antinuclear antibodies Antineutrophil cytoplasmic antibodies Indirect immunofluorescence Automation Autoantibodies Autoimmunity 

Abbreviations

ANA

Antinuclear antibodies

ENA

Extractable nuclear antigens

ANCA

Antineutrophil cytoplasmic antibodies

cANCA

Cytoplasmic ANCA

pANCA

Perinuclear ANCA

MPO

Myeloperoxidase

PR3

Proteinase 3

ELISA

Enzyme-linked immunosorbent assays

IIF

Indirect immunofluorescence

SLE

Systemic lupus erythematosus

RA

Rheumatoid arthritis

SSc

Systemic sclerosis

IIM

Idiopathic inflammatory myopathies

SjS

Sjögren’s syndrome

HEp-2

Human epidermoid laryngeal carcinoma

ACR

American College of Rheumatology

AAV

ANCA-associated vasculitis

References

  1. 1.
    Agmon-Levin N, Damoiseaux J, Shoenfeld Y. Response to: ‘detection of antinuclear antibodies—added-value of solid phase assay?’ by Bossuyt and Fieuws. Ann Rheum Dis. 2014;73:e11.PubMedCrossRefGoogle Scholar
  2. 2.
    Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev. 2008;7:616–20.PubMedCrossRefGoogle Scholar
  3. 3.
    Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol. 2002;117:316–24.PubMedCrossRefGoogle Scholar
  4. 4.
    Meroni PL, Schur PH. ANA screening: an old test with new recommendations”. Ann Rheum Dis. 2010;69:1420–2.PubMedCrossRefGoogle Scholar
  5. 5.
    Nifli AP, Notas G, Mamoulaki M, et al. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods. 2006;311:189–97.PubMedCrossRefGoogle Scholar
  6. 6.
    Smith J, Onley D, Garey C, et al. Determination of ANA specificity using the UltraPlex platform. Ann NY Acad Sci. 2005;1050:286–94.PubMedCrossRefGoogle Scholar
  7. 7.
    Invernizzi P. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;35:436–42.PubMedCrossRefGoogle Scholar
  8. 8.
    American College of Rheumatology, “American College of Rheumatology position statement: methodology of testing for antinuclear antibodies.” 2009. pp. 1–3.Google Scholar
  9. 9.
    Bosch X, Font J, Mirapeix E, et al. Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations. Adv Exp Med Biol. 1993;14:281–6.CrossRefGoogle Scholar
  10. 10.
    Savige JF, Gillis DF, Benson E, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 1999;14:507–13.Google Scholar
  11. 11.
    Craig WY, Ledue TB, Collins MF, et al. Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing. Clin Chem Lab Med. 2006;14:1283–6.Google Scholar
  12. 12.
    Csernok E, Ahlquist D, Ullrich S, et al. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener’s granulomatosis and microscopic polyangiitis. Rheumatology (Oxford). 2002;14:1313–7.CrossRefGoogle Scholar
  13. 13.
    Egerer K, Roggenbuck D, Hiemann R et al. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther. 2010;12:R40.Google Scholar
  14. 14.
    Hiemann R, Hilger N, Michel J, et al. Automatic analysis of immunofluorescencepatterns of HEp-2 cells. Ann NY Acad Sci. 2007;1109:358–71.PubMedCrossRefGoogle Scholar
  15. 15.
    Bonroy C, Verfaillie C, Smith V, et al. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med. 2013;51(9):1771–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Voigt J, Krause C, Rohwäder E, et al. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol. 2012;2012:651058.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Knütter I, Hiemann R, Brumma T, et al. Automated interpretation of ANCA patterns: a new approach in the serology of ANCA-associated vasculitis. Arthritis Res Ther. 2012;14(14):R271.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Kivity S, Gilburd B, Agmon-Levin N, et al. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol. 2011;14:503–9.Google Scholar
  19. 19.
    Willitzki A, Hiemann R, Peters V, et al. New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol. 2012;2012:284740.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Melegari A, Bonaguri C, Russo A, et al. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev. 2012;11:713–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Tozzoli R, Bonaguri C, Melegari A, et al. Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med. 2013;51:129–38.PubMedCrossRefGoogle Scholar
  22. 22.
    Tozzoli R, Antico A, Porcelli B, et al. Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Autoimmun Highlight. 2012;2012(3):59–65.CrossRefGoogle Scholar
  23. 23.
    Bizzaro N, Antico A, Platzgummer S, et al. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev. 2014;13(3):292–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Damoiseaux J, Mallet K, Vaessen M, et al. Automatic reading of ANCA-slides: evaluation of the AKLIDES system. In: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Shoenfeld Y, editors. From prediction to prevention of autoimmune disease. Lengerich, Germany: Pabst Science Publishers; 2011. p. 683–4.Google Scholar
  25. 25.
  26. 26.
    Altman D. Practical statistics for medical research. London, UK: Chapman & Hall; 1991.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • O. Shovman
    • 1
  • N. Agmon-Levin
    • 1
    • 2
  • B. Gilburd
    • 1
  • T. Martins
    • 3
  • A. Petzold
    • 3
  • T. Matthias
    • 3
  • Y. Shoenfeld
    • 1
    • 2
    • 4
  1. 1.Zabludowitz Center for Autoimmune Diseases Sheba Medical CenterTel HashomerIsrael
  2. 2.Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael
  3. 3.AESKU.DIAGNOSTICSWendelsheimGermany
  4. 4.Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael

Personalised recommendations